Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | TAS2R38 | P59533 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL27724287 | 0.89 | TSHR (0.60) | TSHRRECQL | |
| Dimethylformamide SCHEMBL28869383 | 0.87 | — | — | |
| Dimethylformamide SCHEMBL2280000 | 0.87 | — | — | |
| Dimethylformamide SCHEMBL1927321 | 0.87 | TSHR (1.00) | TSHRTAS2R38 | |
| Dimethylformamide SCHEMBL10141201 | 0.87 | — | — | |
| Dimethylformamide SCHEMBL1332179 | 0.87 | — | — | |
| Dimethylformamide SCHEMBL5 | 0.87 | — | — | |
| Dimethylformamide SCHEMBL21436169 | 0.82 | — | — | |
| Dimethylformamide SCHEMBL11130163 | 0.82 | — | — | |
| Dimethylformamide SCHEMBL22749119 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114890999-B | Preparation method of PQQ | 江苏信佑生物有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-111087304-A | Synthesis method of (E) -3- (4-hydroxy-2-methoxyphenyl) methyl acrylate | 晋城天成科创股份有限公司 | 2020-05-01 | — | — | CN | claimed |
| CN-107951268-B | A kind of spring 3D screen cloth composite mattress | 福建省晋江市华宇织造有限公司 | 2019-05-31 | — | — | CN | claimed |
| CN-109485663-A | A kind of preparation method of white light hybrid material | 南京晓庄学院 | 2019-03-19 | — | — | CN | claimed |
| CN-109433158-A | Magnetic nanometer composite material and the preparation method and application thereof for the enrichment of multi-mode peptide fragment | 四川大学 | 2019-03-08 | — | — | CN | claimed |
| CN-109385270-A | A kind of white light emitting material | 南京晓庄学院 | 2019-02-26 | — | — | CN | claimed |
| CN-108395888-B | White light hybrid material, preparation method and application | 南京晓庄学院 | 2019-01-25 | — | — | CN | claimed |
| CN-108395888-A | White light hybrid material, preparation method and application | 南京晓庄学院 | 2018-08-14 | — | — | CN | claimed |
| US-5965746-A | REACTING AN AMINO GROUP-CONTAINING N-CYCLIC COMPOUND WITH MALEIC ANHYDRIDE IN ACETIC ACID TO OBTAIN AN N-CYCLIC MALEAMIC ACID, ADDING HEXAMETHYLDISILAZANE, CYCLIZING TO FORM N-CYCLIC MALEIMIDE, USE AS A FLUORESCENT DYES | AISIN SEIKI KABUSHIKI KAISHA (JP) | 1999-10-12 | — | — | US | claimed |
| JP-1156938-A | — | — | None | — | — | JP | disclosed |
| US-20230203081-A1 | LINCOSAMIDE ANTIBIOTICS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-06-29 | — | — | US | disclosed |
| WO-2021236911-A1 | LINCOSAMIDE ANTIBIOTICS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2021-11-25 | — | — | WO | disclosed |
| WO-2020124666-A1 | LIGHT-RESPONSIVE ADHESIVE AND PREPARATION METHOD THEREFOR | 广州市白云化工实业有限公司 | 2020-06-25 | — | — | WO | disclosed |
| CN-111087304-A | Synthesis method of (E) -3- (4-hydroxy-2-methoxyphenyl) methyl acrylate | 晋城天成科创股份有限公司 | 2020-05-01 | — | — | CN | disclosed |
| US-4018802-A | SKIN DISEASES, GROWTH HORMONE STIMULANTS, THROMBUS PREVENTION, IMMUNOLOGY | MERCK & CO., INC. (US) | 1977-04-19 | — | — | US | disclosed |
| US-4014919-A | Process for preparing methyl jasmonate and related compounds | THE DOW CHEMICAL COMPANY (US) | 1977-03-29 | — | — | US | disclosed |
| US-3991087-A | RENAL VASODILATORS, HYPOTENSIVE AGENTS, ANTITHROMBOTICS | MERCK & CO., INC. (US) | 1976-11-09 | — | — | US | disclosed |
| US-3991106-A | FOR ESTRUS SYNCHRONIZATION AND TREATMENT OF INFERTILITY | MERCK & CO., INC. (US) | 1976-11-09 | — | — | US | disclosed |
| US-3940408-A | CORROSION INHIBITORS IN LUBRICANTS | TEXACO INC. (US) | 1976-02-24 | — | — | US | disclosed |
| US-3940409-A | CORROSION INHIBITOR | TEXACO INC. (US) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203081-A1 | LINCOSAMIDE ANTIBIOTICS AND USES THEREOF | NPEPPS, TLR7, ASNS | TSHR 4067/4885RECQL 3965/4885TAS2R38 3230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.